title: [Dogmatil and vertigo in the aged subject. Apropos of 10 years' prescribing].
abstract: Dogmatil, whose effectiveness on vertigo resulting from peripheral causes is well-documented, is just as potent in central vestibular disorders. In elderly patients, the most common etiology of vertigo is a combination of varying degrees of vertebrobasilar insufficiency, arteriosclerosis and arthrosis of the cervical spine. Patients usually present with a permanent feeling of unsteadiness and anxiety, while electronystagmographic changes are usually of little significance. In most instances, Dogmatil is prescribed in a daily dose of 150 to 200 mg for 4 to 6 weeks, usually in the form of capsules. Three or four days are usually needed for the effect of Dogmatil to become apparent. However, in a non-negligible number of cases, the clinical effect of Dogmatil is clearly noticeable by the patient himself after 48 hours. Dogmatil is remarkably well-tolerated by the elderly, whether it is given as the sole medication or associated with other drugs which cannot be discontinued, such as those prescribed for cardiovascular or respiratory disorders.
mesh_terms: D000368:Aged; D006801:Humans; D013469:Sulpiride / Q000627:therapeutic use*; D013997:Time Factors; D014717:Vertigo / Q000188:drug therapy*
chemical_list: D013469:Sulpiride
vernacular_title: Dogmatil et vertiges du sujet âgé. A propos de dix ans de prescription.